Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Dallah Healthcare to buy stake in IMC after Amanat exit

Dallah Healthcare Company, a listed Saudi Arabian healthcare operator, has signed an agreement to buy 8.2% of the shares of a hospital in Jeddah, International Medical Centre (IMC). The move is part of Dallah Healthcare’s plan to gain a more than 25% stake in the hospital and increase its presence in Jeddah.
November 4, 2021

Is Eurofins’ share price drop an overreaction?

The share price of global lab group Eurofins is down 18% since a high at the end of September. Is it all an overreaction? A raised revenue guidance - but not EBITDA - points to falling margins for the group. 
November 4, 2021

Icade Sante adds first not-for-profit asset

Non-profits continue to open up to sale-and-leasebacks after Icade Sante bought its first property from the sector. HBI explores where else the big REITs have diversified away from for-profits. 
November 4, 2021

Cyberattack hits Fullerton’s vendor partner

A cyberattack on the Agape Connecting People network, a vendor that helps Singapore-based healthcare major Fullerton Health to manage patient appointments and bookings, has resulted in a data leak of Fullerton's patients’ personal information.
November 4, 2021

Flagship PPP in Czech elderly care slows

Earlier this year elderly care providers in Czechia had been looking to a new public-private partnership in Brno as a model for future agreements. However, HBI hears that the project is already slowing and the market is instead looking to alternative models. HBI speaks to David Volny, CEE-focussed partner at PE firm Dynacor Capital, to find out more.
November 3, 2021

More questions for Babylon

The more you look at the Babylon SPAC deal, the more black box it looks. The sheer complexity of the US insurance system makes it impossible for investors to assess its prospects with any accuracy. And then there is the question of the $230m sale of shares made by "certain accredited investors". How much of this went to Babylon founder Ali Parsa?
November 2, 2021

Lab share prices drop from Covid created peaks

In this week’s infographic we take a closer look at the lab market stocks, mapping the percentage change from March 2020 to date for six of the largest players in the sector globally -  Medicover, Sonic Healthcare, Synlab, Dian Diagnostics, Diagnosticos da America (DASA), and Grupo Fleury. What does it show?
October 28, 2021

Doctolib enters Italy with Dottori acquisition

Doctolib, a French company which provides a consultation booking platform in France and Germany, has bought its Italian equivalent, Dottori. The company plans to invest €250m into improving its software and the service it offers to the Italian market.
October 28, 2021

Will Babylon succeed?

Ali Parsa, the founder of Babylon Health, is now a paper billionaire with control of a business with an enterprise value of $3.6bn with an additional $575m in gross proceeds, following its merger with special acquisition vehicle Alkuri. The nearly 90% of the SPAC shareholders who chose to sell before the shares started trading may be kicking themselves - the shares peaked at $16 on October 26, though as of the time of writing are sitting at $10.82, up from the initial opening price of 10$ on October 22.
October 28, 2021

FREE BLOG The real opportunity in digital health

Right now anyone with a half decent digital health story can raise billions on the public markets. Look at Babylon or for an even more extreme example, Pharmeasy in India, which is IPOing with a value of $6bn. A knowledgeable investor claims it was being valued at as little as US$800m in the autumn of 2020.
October 28, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us